MID Labs lands a $51 million funding round led by OrbiMed and Frontline BioVentures for its eye surgery devices.
MID Labs Ltd. said today that it raised a $51 million funding round for its eye surgery devices it plans to use to expand in the U.S. and China.
The round, led by OrbiMed and Frontline BioVentures, also included Softbank China Venture Capital, Allen Chao and Sungent BioVenture, according to a press release.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rzEHiO
Cap comentari:
Publica un comentari a l'entrada